METTL3 and adrenal cortex carcinoma: Similar with TCGA analytical results, METTL3 (p = 0.05, HR = 2.1), HNRNPC (p = 0.0033, HR = 3.3) and RBM15 (p < 0.011, HR = 2.7) can still affect ACC survival outcomes (Figure 3D, 3F, 3H).